Critical quality appraisal of randomized controlled trials with traditional Chinese medicines for the coronavirus disease 2019
Description
CONCLUSION: The overall quality of RCTs investigating TCM for COVID-19 was appraised as moderate-to-high that was substandard and needs to be continuously improved, especially for RCTs published in Chinese, in the future.
